Focussen bij mensen met de gedragsvariant van frontotemporale dementie

Focusing in people with behavioral variant of frontotemporal dementia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27059

Enrollment

Registered

2021-03-18

Start date

2021-04-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disinhibited behavior in the behavioral variant of frontotemporal dementia

Interventions

In this intervention study, the adapted intervention ‘Focusing in the behavioral variant of frontotemporal dementia’ will be implemented at two YOD SCU's. As a part of the intervention health care pro

Eligibility

Inclusion criteria

Inclusion criteria: Residents of young-onset dementia special care units (YOD SCU’s); a) diagnosed with the behavioral variant of frontotemporal dementia, b) who show disinhibited behavior and c) have been admitted at the YOD SCU for at least 6 weeks

Exclusion criteria

Exclusion criteria: - Lack of informed consent - Advanced dementia

Design outcomes

Primary

Measure	Time frame
•Specific disinhibited behavior, scored on a list developed for the specific disinhibited behavior of a resident by an observer •Well-being, scored on a adjusted version of the EQ-5D thermometer •Intervention moments by health care professionals, established in advance to the multiple case study during a visitation meeting, behavioral visit or multidisciplinary consultation and scored by an observer •Current use of psychotropic drugs (in advance to and at the end of the multiple case study), identified by a (retrospective) view of the electronic prescription systems	—

Measure

Time frame

•Specific disinhibited behavior, scored on a list developed for the specific disinhibited behavior of a resident by an observer •Well-being, scored on a adjusted version of the EQ-5D thermometer •Intervention moments by health care professionals, established in advance to the multiple case study during a visitation meeting, behavioral visit or multidisciplinary consultation and scored by an observer •Current use of psychotropic drugs (in advance to and at the end of the multiple case study), identified by a (retrospective) view of the electronic prescription systems

—

Secondary

Measure	Time frame
Descriptive measures: • Relevant medical history (prior to and during admission) with specific attention for the disinhibited behavior. This will be identified using patient records. Eventually, health care professionals and/or family members will be consulted. • Dementia severity with the Global Detoriation Scale (GDS) • Cognitive functions with the Mini Mental State Examination (MMSE), Severe Impairment Battery Short Version (SIB-S) and Frontal Assessment Battery (FAB) • Neuropsychiatric symptoms with the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) • Disinhibition and related behaviors with the Frontal Behavioral Inventory (FBI) and Middelheim Frontality Score (MFS)	—

Measure

Time frame

Descriptive measures: • Relevant medical history (prior to and during admission) with specific attention for the disinhibited behavior. This will be identified using patient records. Eventually, health care professionals and/or family members will be consulted. • Dementia severity with the Global Detoriation Scale (GDS) • Cognitive functions with the Mini Mental State Examination (MMSE), Severe Impairment Battery Short Version (SIB-S) and Frontal Assessment Battery (FAB) • Neuropsychiatric symptoms with the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) • Disinhibition and related behaviors with the Frontal Behavioral Inventory (FBI) and Middelheim Frontality Score (MFS)

—

Contacts

Public ContactMSc, PhD Christian Bakker

Radboudumc

Christian.Bakker@radboudumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)